Engineering LNPs with polysarcosine lipids for mRNA delivery
Since the approval of the lipid nanoparticles (LNP)-mRNA vaccines against the SARS-CoV-2 virus, there has been an increased interest in the delivery of mRNA through LNPs. However, current LNP formulations contain PEG lipids, which can stimulate the generation of anti-PEG antibodies. The presence of...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
KeAi Communications Co., Ltd.
2024-07-01
|
| Edice: | Bioactive Materials |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2452199X24000987 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|